RSCH Stock Overview
PT Charlie Hospital Semarang Tbk operates in the private hospital business in Indonesia.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
PT Charlie Hospital Semarang Tbk Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | Rp230.00 |
| 52 Week High | Rp262.00 |
| 52 Week Low | Rp102.00 |
| Beta | 0 |
| 1 Month Change | 21.69% |
| 3 Month Change | 16.16% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 75.57% |
Recent News & Updates
Recent updates
Shareholder Returns
| RSCH | ID Healthcare | ID Market | |
|---|---|---|---|
| 7D | 2.7% | 3.9% | 3.1% |
| 1Y | n/a | 3.3% | 3.0% |
Return vs Industry: Insufficient data to determine how RSCH performed against the ID Healthcare industry.
Return vs Market: Insufficient data to determine how RSCH performed against the ID Market.
Price Volatility
| RSCH volatility | |
|---|---|
| RSCH Average Weekly Movement | 16.0% |
| Healthcare Industry Average Movement | 5.1% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in ID Market | 12.1% |
| 10% least volatile stocks in ID Market | 2.4% |
Stable Share Price: RSCH's share price has been volatile over the past 3 months.
Volatility Over Time: RSCH's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of ID stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | 212 | H. Junianto | charliehospital.co.id |
PT Charlie Hospital Semarang Tbk operates in the private hospital business in Indonesia. It offers medical services and support, inpatient, and medical check-up services, as well as operates wellness center. The company was founded in 2019 and is based in Kendal, Indonesia.
PT Charlie Hospital Semarang Tbk Fundamentals Summary
| RSCH fundamental statistics | |
|---|---|
| Market cap | Rp609.50b |
| Earnings (TTM) | -Rp1.11b |
| Revenue (TTM) | Rp42.16b |
14.5x
P/S Ratio-548.2x
P/E RatioIs RSCH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RSCH income statement (TTM) | |
|---|---|
| Revenue | Rp42.16b |
| Cost of Revenue | Rp30.92b |
| Gross Profit | Rp11.24b |
| Other Expenses | Rp12.36b |
| Earnings | -Rp1.11b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.42 |
| Gross Margin | 26.67% |
| Net Profit Margin | -2.64% |
| Debt/Equity Ratio | 0% |
How did RSCH perform over the long term?
See historical performance and comparison